Letter

United Kingdom research governance strategy

BMJ 2004; 328 doi: 10.1136/bmj.328.7430.49-b (Published 1 January 2004)
Cite this as: BMJ 2004;328:49.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Reforming clinical research and development in England

  1. Richard Sullivan, head, clinical programmes (richard.sullivan@cancer.org.uk)
  1. Cancer Research UK, London WC2A 3PX

    EDITOR—The National Cancer Research Institute does not set the research strategies of its partners, as Kerrison et al say.1 They also do not grasp its mission, which is to double the number of patients entering cancer clinical trials by 2005 (a target it has already surpassed).

    They suggest that the formal research networks in cancer were set up as a result of the outcomes of the Pharmaceutical Industry Competitiveness Taskforce. The institute was created …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular